SARS News and Research

RSS

Phenotyping identifies long COVID subtypes

Researchers discuss the phenotypes associated with long COVID inflammation.

14 Jun 2023

An analysis of the differential effect and the impact of SARS-CoV-2 infection on semen quality

Study analyzed the impact of SARS-CoV-2 infection on semen quality.

14 Jun 2023

DYRK1A gene may dictate susceptibility to multiple highly pathogenic coronaviruses

Entry of the SARS-CoV-2 virus into human tissues depends on the activity of a host gene that regulates production of a key viral receptor, according to a study publishing June 13th in the open access journal PLOS Biology by Madison Strine and Craig Wilen of Yale University, US, and colleagues.

13 Jun 2023

Berlin scientists further improve nasal vaccine against coronavirus

After having successfully tested a mucosal vaccine against coronavirus in animals just months ago, Berlin scientists have now further developed their live SARS-CoV-2 vaccine.

13 Jun 2023

Using heart and lung stem cells to better understand how COVID-19 impacts different organs

Researchers have used heart and lung stem cells infected with the virus that causes COVID-19 to better understand how the disease impacts different organs, paving the way for more targeted treatments.

13 Jun 2023

Researchers explore viral emissions in a phase 1, open label, first-in-human SARS-CoV-2 experimental infection study

Researchers explored the release of viral particles into the environment and air after SARS-CoV-2 human challenge.

13 Jun 2023

When COVID meets Candida: exploring the alarming surge of C. auris in Israel

CDC reports an outbreak involving Candida auris (C. auris) in Israel.

13 Jun 2023

COVID-19 vaccine hesitancy doesn't spill over to routine childhood vaccinations, US polls reveal

Media attention on COVID-19 vaccine hesitancy in the US raises concerns about the impact on routine childhood immunizations, with potential disruptions to vaccination rates and school-based requirements.

13 Jun 2023

New cell culture model generates the alveolar macrophage in the lab

Researchers at Texas Biomedical Research Institute have succeeded in generating the lung's most important immune cell, the alveolar macrophage, in the lab.

12 Jun 2023

Metformin shows promising antiviral activity against SARS-CoV-2

Metformin, a widely available oral medication, reduces SARS-CoV-2 viral load by 3.6-fold in outpatient trial, offering a potential treatment option. Ivermectin and fluvoxamine show no significant virologic effect.

12 Jun 2023

Metformin reduces risk of long COVID by over 40%

Researchers discuss whether metformin, ivermectin, or fluvoxamine could reduce the risk of long COVID if administered shortly after infection.

12 Jun 2023

Many adults infected with COVID-19 report only partial or no recovery of taste or smell

During the COVID-19 pandemic, many patients experienced a loss of taste and smell during and after being infected with SARS-CoV-2.

12 Jun 2023

Study:Overactive inflammatory response could be at the root of many long COVID cases

An overactive inflammatory response could be at the root of many long COVID cases, according to a new study from the Allen Institute and Fred Hutchinson Cancer Center.

12 Jun 2023

Common diabetes drug prevents the development of long COVID, study finds

In a new study published in The Lancet Infectious Diseases, University of Minnesota researchers found that metformin, a drug commonly used to treat diabetes, prevents the development of long COVID.

9 Jun 2023

Mechanistic insights into how the SARS-CoV-2 virus affects the nervous system, alters its function, and causes neuropathology

Study demonstrates that SARS-CoV-2 infection and viral fusogens cause glial and neuronal fusion.

9 Jun 2023

Investigating the alveolar type II reparative response in COVID-19 pneumonia

Researchers investigated the alveolar type II reparative response in COVID-19 pneumonia.

9 Jun 2023

SARS-CoV-2 hijacks body's metabolism to amplify COVID-19 severity

In a review article published in the journal Signal Transduction and Targeted Therapy, scientists have discussed host metabolic alteration triggered by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its effect on disease severity.

9 Jun 2023

MIS-C in children: A distinct autoimmune response to COVID-19 unveiled

The study reveals that MIS-C patients, post SARS-CoV-2 infection, develop a unique immune response against the virus' N protein, indicating a cross-reactivity with the self-protein SNX8, which might link the infection to the ensuing inflammatory syndrome.

8 Jun 2023

Gut health boost: Functional foods and herbs show promise in tackling SARS-CoV-2 variants

Functional foods and natural herbs have the potential to enhance immune function and maintain gut microbiota diversity. This review explores their role in mitigating the impact of SARS-CoV-2 variants on gut health and overall well-being.

8 Jun 2023

Scientists unlock virus-fighting power with synthetic nanobody platform

Discovery and validation of nanobodies, a promising class of biologics, for viral infection prevention and treatment, including anti-SARS-CoV-2 nanobodies with enhanced neutralization properties through synergistic pairing. The study demonstrates the potential of nanobodies in developing effective therapies against viral infections.

8 Jun 2023

SARS News and Research

Phenotyping identifies long COVID subtypes

An analysis of the differential effect and the impact of SARS-CoV-2 infection on semen quality

DYRK1A gene may dictate susceptibility to multiple highly pathogenic coronaviruses

Berlin scientists further improve nasal vaccine against coronavirus

Using heart and lung stem cells to better understand how COVID-19 impacts different organs

Researchers explore viral emissions in a phase 1, open label, first-in-human SARS-CoV-2 experimental infection study

When COVID meets Candida: exploring the alarming surge of C. auris in Israel

COVID-19 vaccine hesitancy doesn't spill over to routine childhood vaccinations, US polls reveal

New cell culture model generates the alveolar macrophage in the lab

Metformin shows promising antiviral activity against SARS-CoV-2

Metformin reduces risk of long COVID by over 40%

Many adults infected with COVID-19 report only partial or no recovery of taste or smell

Study:Overactive inflammatory response could be at the root of many long COVID cases

Common diabetes drug prevents the development of long COVID, study finds

Mechanistic insights into how the SARS-CoV-2 virus affects the nervous system, alters its function, and causes neuropathology

Investigating the alveolar type II reparative response in COVID-19 pneumonia

SARS-CoV-2 hijacks body's metabolism to amplify COVID-19 severity

MIS-C in children: A distinct autoimmune response to COVID-19 unveiled

Gut health boost: Functional foods and herbs show promise in tackling SARS-CoV-2 variants

Scientists unlock virus-fighting power with synthetic nanobody platform

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News